540359
PARMAX
Start SIP
Invest Now
Start SIP in PARMAX
Parmax Pharma live price: ₹27.8. It opened at ₹28 vs previous close ₹27; intraday high/low: ₹28/₹28. The 50 & 200 DMA stand at ₹32.31/₹34.92.
Parmax Pharma Performance
- Low
- ₹28
- High
- ₹28
- 52 Week Low
- ₹25
- 52 Week High
- ₹55
- Open Price₹28
- Previous Close₹27
- Volume4
- 50 DMA₹32.31
- 100 DMA₹33.24
- 200 DMA₹34.92
Investment Returns
- Over 1 Month -12.99%
- Over 3 Month -17.36%
- Over 6 Month -18.59%
- Over 1 Year -33.4%
Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!
Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -2.1
- PEG Ratio
- 0
- Market Cap Cr
- 10
- P/B Ratio
- -1.7
- Average True Range
- 2.85
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.76
- RSI
- 37.19
- MFI
- 48.07
Parmax Pharma Financials
Parmax Pharma Technicals
EMA & SMA
Current Price
₹27.80
+
0.37
(1.35%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹31.12
- 50 Day
- ₹32.31
- 100 Day
- ₹33.24
- 200 Day
- ₹34.92
Resistance and Support
27.09
- R3 33.04
- R2 30.94
- R1 29.19
- S1 25.34
- S2 23.24
- S3 21.49
Parmax Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Parmax Pharma F&O
About Parmax Pharma
- NSE Symbol
- PARMAX
- BSE Symbol
- 540359
- Managing Director
- Dr. Umang Alkesh Gosalia
- ISIN
- INE240T01014
Similar Stocks to Parmax Pharma
Parmax Pharma FAQs
Parmax Pharma share price is ₹27 As on 13 March, 2026 | 09:21
The Market Cap of Parmax Pharma is ₹10.4 Cr As on 13 March, 2026 | 09:21
The P/E ratio of Parmax Pharma is -2.1 As on 13 March, 2026 | 09:21
The PB ratio of Parmax Pharma is -1.7 As on 13 March, 2026 | 09:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.